Display search results for ** instead (90 products)

Showing 41-50 of 90

The Canadian Automotive Industry is faced with challenging business conditions.Persistent excess capacity,sluggish motor vehicle demand,rapid consolidation of major automakers,appreciating Canadian dollar, rising energy prices, political instability,and policy changes are some of the key growth determining forces for its automotive industry.This Co...

USD 450.00

USD 337.50 save 25 %

The Canadian Automotive Industry is faced with challenging business conditions. Aging baby boomers, changing consumer preferences resulting in emergence of new growth drivers for the industry, availability of skilled labor in the future, Canada-U.S. border congestion, and growth of public transit system are all expected to have an impact on the veh...

USD 450.00

USD 337.50 save 25 %

The Mexican Automotive Industry is faced with challenging business conditions.Implications of the 2006 Presidential Elections, phase-in of U.S. EPA Tier-II emission norms, EPA with Japan, and other key political and policy developments are expected to have far-reaching effects on its manufacturing and specifically on automotive industry.This Countr...

USD 450.00

USD 337.50 save 25 %

The Mexican automotive industry has attracted a great deal of interest from the leading automakers across the globe due to its inherent cost differential in the manufacturing process and geographical proximity to the United States. Over the last two years, the industry witnessed a surge in its domestic demand, greenfield investments, and a growing ...

USD 450.00

USD 337.50 save 25 %

Mexico is faced with increasing demand for mobility. This trend is expected to stay in Mexico during the medium term. Conducive factors like increasing per capita income, growth in consumer credit, and greater affordability among the growing middle class consumer base are responsible for this trend. Mexico has a huge young and employable population...

USD 450.00

USD 337.50 save 25 %

This issue of Vital Signs, released on March 31, 2014, discusses the premium price tag of Gileads Sovaldi, Sonys genomic partnership with Illumina, and Craig Venters latest venture, Human Longevity, Inc.

USD 450.00

USD 337.50 save 25 %

This issue of Vital Signs, released on July 31, 2013, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Pharma/Biotech, In Vitro Diagnostics, Advanced Medical Technology and Connected Health.

USD 450.00

USD 337.50 save 25 %

This issue of Vital Signs, released on July 31, 2013, provides an analysis of sequestration measures that were in effect March 1st, 2013 on academic and government laboratory spending on life science research tools and products. Additionally, a company spotlight is provided for BioScale in Lexington, MA. The company provides a highly innovative pr...

USD 450.00

USD 337.50 save 25 %

This issue of Vital Signs, released on August 31, 2013, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Pharma/Biotech, Advanced Medical Technology and Connected Health.

USD 450.00

USD 337.50 save 25 %

This issue of Vital Signs, released on September 30, 2013, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Pharma/Biotech, In Vitro Diagnostics, Advanced Medical Technology and Connected Health.

USD 450.00

USD 337.50 save 25 %

Showing 41-50 of 90